Dr. Cairo confesses she never stopped pairing endocrine therapy with HER2-directed drugs; Dr. Mouabbi celebrates now-arriving translational data that finally back her up, proving an “ally” like capecitabine or letrozole can ride shotgun with an ADC.
Concurrent Endocrine: Old-School?
Recommended Videos
